These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 936575)

  • 1. [Reasons for lowered resistance to Krebs 2 ascitic carcinoma in mice in a state of hyporeactivity (tolerance) to a viral interferon inducer].
    Marchenko VI; Pokidysheva LN; Zubanova NA; Voronina FV
    Vopr Virusol; 1976; (2):176-9. PubMed ID: 936575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of hyporeactivity (tolerance) to a viral interferon inducer on the transplantation of Krebs 2 ascitic carcinoma cells in mice].
    Marchenko VI; Pokidysheva LN
    Vopr Virusol; 1974; (4):396-400. PubMed ID: 4439850
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stimulation of the inhibiting effect of interferon on the growth of ascitic carcinoma in relation to host responsiveness and cells].
    Pokidysheva LN; Voronina FV; Khesin IaE; Marchenko VI
    Vopr Virusol; 1976; (5):591-6. PubMed ID: 1007229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between manifestation of hyporeactivity (tolerance) in interferon production and the presence of a viral interferon inductor in the cells of the tolerant animal].
    Marchenko VI; Zubanova NA; Diuĭsalieva RG; Voronina FV; Delimbetova GA
    Vopr Virusol; 1977; (2):206-15. PubMed ID: 898897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a number of antitumor preparations on RNA- and protein-synthesizing processes and viral interferon induction in Krebs 2 ascites carcinoma cells].
    Shloma DV; Krispin TI; Balandin IG
    Vopr Virusol; 1982; 27(6):735-8. PubMed ID: 6186093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differences in the antiviral and antioncogenic action of interferons produced in murine peritoneal cells and in Krebs-2 ascitic carcinoma cells].
    Marchenko VI; Pokidysheva LN; Malinovskaia VV; Aliab'eva TI; Khesin IaE
    Vopr Virusol; 1977; (3):344-8. PubMed ID: 198969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levels.
    Rathová V; Kocisková D; Borecký L
    Acta Virol; 1975 Apr; 19(2):158-61. PubMed ID: 239563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differences in the properties of the interferons produced by the leukocytes of healthy persons and of cancer and leukemia patients].
    Pokidysheva LN; Marchenko VI; Zubanova NA; Moĭsiadi SA; Fedorova IuB
    Vopr Virusol; 1979; (5):532-5. PubMed ID: 506207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological, cytochemical and biochemical changes in peritoneal macrophages (normal, activated and tolerant) in the process of interferon formation].
    Khesin IaE; Voronina FV; Marchenko VI; Rusanova NA; Balandin IG
    Vopr Virusol; 1973; 18(3):302-8. PubMed ID: 4769532
    [No Abstract]   [Full Text] [Related]  

  • 10. Viral factors required for interferon induction by Newcastle disease virus in mouse macrophages and chicken embryo cells.
    Azuma M
    J Gen Virol; 1976 Jan; 30(1):51-62. PubMed ID: 942745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of age-related serum factors in the mechanism of interferon production].
    Malinovskaia VV; Pokidysheva LN; Balakireva NN
    Vopr Virusol; 1980; (3):298-303. PubMed ID: 6159732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of experimental infection of mice with encephalomyocarditis (EMC) virus on interferon production by alveolar and peritoneal cells in vitro.
    Lobodzińska M; Albin M; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):91-5. PubMed ID: 6169322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of temperature on interferon production in mouse lymphocytes.
    Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):503-8. PubMed ID: 2484832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological and histochemical studies on cultures of mouse peritoneal leucocytes during interferon formation.
    Khesin YE; Voronina FV; Amchenkova AM
    Acta Virol; 1970 Nov; 14(6):445-52. PubMed ID: 4099770
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergic effects of interferon and interferon inducer against ectromelia virus infection in mice.
    Imanishi J; Won SJ; Matsubara M; Nomura H; Kishida T
    Biken J; 1980 Jun; 23(2):77-81. PubMed ID: 6161603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyporeactivity due to infection: recognition of a transferable hyporeactive factor in the serum of encephalomyocarditis virus-infected mice.
    Stringfellow DA; Glasgow LA
    Infect Immun; 1974 Dec; 10(6):1337-42. PubMed ID: 4373396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the interferon protein in the animal: general considerations.
    Ho M
    Tex Rep Biol Med; 1977; 35():78-83. PubMed ID: 99834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon and humoral immune response in experimental influenza: infection with A/PR8 virus adapted to the mouse.
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):323-8. PubMed ID: 6160829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and initial characterization of spotted souslik (Spermophilus suslicus) interferon.
    Kandefer-Szerszeń M; Kamińska T
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):451-7. PubMed ID: 6085464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ethylene diamine tetraacetate (EDTA) on the interferon-inducing activity of Newcastle disease virus (NDV) in vivo. Brief report.
    Taguchi F; Nishimura Y
    Arch Virol; 1984; 81(3-4):371-5. PubMed ID: 6206828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.